News | January 18, 2024
Taro announces merger agreement with Sun Pharma
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
The company disclosed that several employees of a subsidiary had their business email addresses stolen
Automated parallel capillary electrophoresis system simplifies protein analysis
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
The workshop was conducted as a part of the NITI–State workshop series
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
Subscribe To Our Newsletter & Stay Updated
